Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-14 · accession 0000905148-25-001215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-15 | 2025-04-14 | TXMD | Walker Marlan D | CEO | P - Purchase | $1.00 | +490 | 73.6K | +0.7% | +$490 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-14 | P | A | 490 | $1.00 | 73,639 | D | — | — |